- Home
- ZLAB vs VERX Comparison
ZLAB vs VERX Comparison
Compare ZLAB & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | VERX |
|---|---|---|
| Founded | 2013 | 1978 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | VERX |
|---|---|---|
| Price | $18.40 | $11.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $49.60 | $24.25 |
| AVG Volume (30 Days) | 867.0K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $460,156,000.00 | ★ $748,444,000.00 |
| Revenue This Year | $9.75 | $12.78 |
| Revenue Next Year | $26.03 | $11.61 |
| P/E Ratio | ★ N/A | $302.25 |
| Revenue Growth | ★ 15.33 | 12.25 |
| 52 Week Low | $15.96 | $10.59 |
| 52 Week High | $41.20 | $36.75 |
Technical Indicators
Market Signals| Indicator | ZLAB | VERX |
|---|---|---|
| Relative Strength Index (RSI) | 52.14 | 36.71 |
| Support Level | $18.29 | $11.03 |
| Resistance Level | $19.49 | $12.54 |
| Average True Range (ATR) | 0.65 | 0.70 |
| MACD | 0.23 | -0.22 |
| Stochastic Oscillator | 77.19 | 4.05 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.